ARTHEx Biotech vs Dynacure

ARTHEx Biotech logo

ARTHEx Biotech

Developing microRNA modulators for diseases with unmet medical needs

28 employees · est. 2019 · Paterna, Spain

VS
Dynacure logo

Dynacure

Dynacure develops new treatments for orphan disorders, focusing on CNM through Dyn101 program with Ionis

est. 2016 · Illkirch-graffenstaden, Fran...

Dynacure is the older company (2019 vs 2016).

Side-by-Side Comparison

ARTHEx Biotech Dynacure
Founded
2019 2016 older
Headquarters
Paterna, Spain Illkirch-graffenstaden, France
Employees
28 Not tracked yet
Industry
Biotechnology Biotechnology, Health Care, Life Sciences
Funding Stage
Series B Series C
Total Funding
$62.95M $100.27M
Funding Rounds
6 3
Services
Not tracked yet Development and execution of RNA-targeted therapies for oncology
Target Customers
Not tracked yet Patients with cancer and healthcare professionals
Taxonomy
BiotechBiomedical ResearchOligonucleotide TherapiesMicroRNA ModulationGenetic DiseasesDrug Development +8 Rare Disease Drug DevelopmentOrphan DisordersClinical-stage Drug DevelopmentAntisense MedicineRNA-targeted Drug DiscoveryDynamin 2 Protein Modulation +8
Website
arthexbiotech.com dynacure.com
ARTHEx Biotech logo

About ARTHEx Biotech

Analyzing ARTHEx Biotech, a spin-off biotech company from the University of Valencia, it is focused on developing microRNA modulators for diseases with unmet medical needs. The company has proprietary platform that enables efficient development of investigational miR-modulating oligonucleotides desi...

Dynacure logo

About Dynacure

Dynacure is a biotechnology startup that specializes in developing new treatments for rare orphan disorders, with a primary focus on Centronuclear Myopathies (CNM) through its Dyn101 program. This initiative aims to address the severe effects of CNM, particularly on young individuals, by altering th...

Also comparing in this category

Comparing more than these two?

Get ARTHEx Biotech, Dynacure and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does ARTHEx Biotech compare?

A PDF of ARTHEx Biotech and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Frequently Asked Questions

ARTHEx Biotech was founded in 2019, based in Paterna, Spain, with 28 employees. Analyzing ARTHEx Biotech, a spin-off biotech company from the University of Valencia, it is focused on developing microRNA modulators for diseases with unmet medical needs. The company has proprietary. Dynacure was founded in 2016, based in Illkirch-graffenstaden, France. Dynacure is a biotechnology startup that specializes in developing new treatments for rare orphan disorders, with a primary focus on Centronuclear Myopathies (CNM) through its Dyn101 program. This ini.
ARTHEx Biotech has raised $62.95M and Dynacure $100.27M. Latest stage: ARTHEx Biotech Series B, Dynacure Series C.
Both work in Biotechnology.

Compare ARTHEx Biotech with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at ARTHEx Biotech on 11 Sep 2024, and Dynacure on 29 May 2025. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes